Page last updated: 2024-10-23

bisindolylmaleimide i and Uterine Neoplasms

bisindolylmaleimide i has been researched along with Uterine Neoplasms in 1 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Uterine Neoplasms: Tumors or cancer of the UTERUS.

Research Excerpts

ExcerptRelevanceReference
" In this study we used okadaic acid, an inhibitor of serine/threonine phosphatase 1 and 2 A, as a probe to explore the signaling pathway regulating the expression of p100 RasGAP in JEG-3 human placental choriocarcinoma cells."3.70A protein kinase C-independent pathway leading to c-Jun-dependent expression of 100-kDa Ras GTPase-activating protein in JEG-3 human choriocarcinoma cells. ( Bourgeade, MF; Cayre, YE; Thang, MN; Ye, F, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ye, F1
Bourgeade, MF1
Cayre, YE1
Thang, MN1

Other Studies

1 other study available for bisindolylmaleimide i and Uterine Neoplasms

ArticleYear
A protein kinase C-independent pathway leading to c-Jun-dependent expression of 100-kDa Ras GTPase-activating protein in JEG-3 human choriocarcinoma cells.
    European journal of biochemistry, 2000, Volume: 267, Issue:6

    Topics: Cell Differentiation; Choriocarcinoma; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression

2000